|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Rockefeller University Press,
0021-9525/2000//17 $5.00
The Journal of Cell Biology, Volume 149, Number 1,
, 2000 17-22
Brief Report |
Keratin-Dependent, Epithelial Resistance to Tumor Necrosis Factor-Induced Apoptosis
rgoshima{at}burnham-inst.org
Tumor necrosis factor (TNF) is a cytokine produced by macrophages and T lymphocytes that acts through two distinct receptors, TNFR1 (60 kD, CD120a) and TNFR2 (80 kD, CD120b), to affect cellular proliferation, differentiation, survival, and cell death. In addition to its proinflammatory actions in mucosal tissue, TNF is important for liver regeneration. Keratin 8 (K8) and keratin 18 (K18) form intermediate filaments characteristic of liver and other single cell layered, internal epithelia and their derivative cancers. K8-deficient (K8–) mice, which escape embryonic lethality, develop inflammatory colorectal hyperplasia, mild liver abnormalities, and tolerate hepatectomy poorly. We show that normal and malignant epithelial cells deficient in K8 and K18 are
100 times more sensitive to TNF-induced death. K8 and K18 both bind the cytoplasmic domain of TNFR2 and moderate TNF-induced, Jun NH2-terminal kinase (JNK) intracellular signaling and NF
B activation. Furthermore, K8– and K18– mice are much more sensitive to TNF dependent, apoptotic liver damage induced by the injection of concanavalin A. This moderation of the effects of TNF may be the fundamental function of K8 and K18 common to liver regeneration, inflammatory bowel disease, hepatotoxin sensitivity, and the diagnostic, persistent expression of these keratins in many carcinomas.
Key Words: cytoskeleton intermediate filament inflammatory bowel disease tumor necrosis factor receptor 2
© 2000 The Rockefeller University Press
Abbreviations used in this paper: CHX, cycloheximide; ConA, concanavalin A; GST, glutathione S-transferase; JNK, Jun NH2-terminal kinase; K8, keratin 8; K18, keratin 18; K8–, homozygous null Krt2-8 targeted mutation; K18–, homozygous null Krt1-18 targeted mutation; TNF, tumor necrosis factor; TNFR1, tumor necrosis factor receptor 1; TNFR2, tumor necrosis factor receptor 2; TRAF, TNF receptor associated factors.
Related Article
This article has been cited by other articles:
|
|